Delcath Systems Inc DCTH

NAS: DCTH | ISIN: US24661P8077   30/04/2024
5,200 USD (-0,19%)
(-0,19%)   30/04/2024

4 april 2024 · Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

26 maart 2024 · Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update · Persbericht

20 maart 2024 · Delcath Systems Closes $7 Million Private Placement · Persbericht

19 maart 2024 · Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call · Persbericht

18 maart 2024 · Delcath Systems Appoints Martha S. Rook as Chief Operating Officer · Persbericht

15 maart 2024 · Delcath Systems Announces $7 Million Private Placement · Persbericht

8 maart 2024 · Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

8 maart 2024 · Delcath Systems to Participate in Upcoming Investor Conferences · Persbericht

22 februari 2024 · Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) · Persbericht

16 februari 2024 · Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

31 januari 2024 · Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024 · Persbericht

23 januari 2024 · Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference · Persbericht

16 januari 2024 · Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™ · Persbericht

12 januari 2024 · Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

7 december 2023 · Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research · Persbericht

6 november 2023 · Delcath Systems to Host Third Quarter 2023 Results Call · Persbericht

16 oktober 2023 · Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers · Persbericht

10 oktober 2023 · Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor Conference · Persbericht

3 oktober 2023 · Delcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023 · Persbericht

27 september 2023 · Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

Mijn selecties